(PharmaNewsWire.Com, February 09, 2024 ) The report "Bone Cement & Glue Market by Bone Cement (PMMA, Calcium Phosphate), Bone Glue (Natural, Synthetic), Loading (Antibiotic Loaded), Application (Arthroplasty, Kyphoplasty, Vertebroplasty), End User (Hospitals, ASCS, Clinics) - Global Forecast to 2028", is projected to reach USD 2,248 million by 2028 from USD 1,644 million in 2023, at a CAGR of 6.5% during the forecast period.
The growth of this market is majorly driven by Growing number of road traffic accidents and rising number of surgical procedures. However, High costs and Product-related complications may challenge the growth of this market.
France in European Bone cement & glue market to witness the highest shares during the forecast period.
The Europe Bone cement & glue market is segmented into Germany, France, the UK, and the Rest of Europe. France is projected to occupy the highest share during the forecast period. The major factors contributing to the growth of this market are the high prevalence of Orthopedic Conditions, the growing geriatric population, In addition, France has a well-developed healthcare system with access to advanced medical technologies and treatments. This infrastructure supports the adoption of bone cement and glue products in various orthopedic and dental procedures. Likewsie, France has a skilled workforce of healthcare professionals, including orthopedic surgeons, who are adept at using bone cement and glue products in surgical procedures.
Hospitals, & Ambulatory Surgical Centers in End user’ Bone cement & glue market to witness the highest growth rate during the forecast period.
Based on the end user, the Bone cement & glue market is segmented into Hospitals, & Ambulatory Surgical Centers, and Clinics/Physician offices. The Hospitals, & Ambulatory Surgical Centers registered the highest CAGR, increasing orthopedic Surgical Procedures, Hospitals and ASCs are key providers of joint replacement surgeries, such as total hip arthroplasty (THA) and total knee arthroplasty (TKA), moreover Hospitals and ASCs cater to patients of all ages, but the aging population is more likely to require orthopedic surgeries that involve bone cement and glue. As the global population ages, the demand for joint replacement surgeries and other orthopedic procedures is increasing, benefiting the bone cement and glue market.
China dominates the Asia Pacific Bone cement & glue market.
The APAC amniotic products market is segmented into Japan, China, India, and Rest of Apac. In 2022, China accounted for the largest share of the Asian Bone cement & glue market. The large share of China can be attributed to the economic growth in the country, rising incidence of orthopedic cases, significantly high cases of road accidents, increasing disposable income of the middle-class population, growth in the geriatric population, and favourable government support.
The significant players in the Bone cement & glue market are Stryker (US), Zimmer Biomet (US), DePuy Synthes (a subsidiary of Johnson & Johnson - US), Enovis (US), Heraeus Holding (Germany), Medtronic (Ireland)
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
